Last 12 months
Inside the activity.
1 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 1 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2023 Filed May 5, 2023 20:09 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
GrantPerformance Rights · Derivative | 12,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000028 · wf-form4_168331735400205.xml · derivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,157 Underlying: Common Stock · 12,422 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:09 UTC |
Perry James EEVP, CFO
|
GrantPerformance Rights · Derivative | 3,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000029 · wf-form4_168331738044066.xml · derivative · entry 1 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,635 Underlying: Common Stock · 3,037 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:10 UTC |
Sullivan DonEVP, GM Contractor Solutions
|
GrantPerformance Rights · Derivative | 3,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000030 · wf-form4_168331739809134.xml · derivative · entry 1 Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,435 Underlying: Common Stock · 3,037 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:35 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 236 | $141.61 | $33,419.96 |
DisclosureSEC source: 0001624794-23-000020 · wf-form4_168185014021968.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,584 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.36 to $141.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:35 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 521 | $140.82 | $73,367.22 |
DisclosureSEC source: 0001624794-23-000020 · wf-form4_168185014021968.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,820 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.36 to $141.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:35 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 229 | $139.79 | $32,011.91 |
DisclosureSEC source: 0001624794-23-000020 · wf-form4_168185014021968.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,341 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.32 to $140.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:35 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 14 | $138.28 | $1,935.92 |
DisclosureSEC source: 0001624794-23-000020 · wf-form4_168185014021968.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,570 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.28 to $138.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Alverson LukeSVP, GC & Secretary
|
Exercise / conversionPerformance Rights · Derivative | 2,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000019 · wf-form4_168081442122928.xml · derivative · entry 3 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,635 Underlying: Common Stock · 2,273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 46 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 46 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 46 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Alverson LukeSVP, GC & Secretary
|
Tax withholdingCommon Stock | 1,631 | $138.93 | $226,594.83 |
DisclosureSEC source: 0001624794-23-000019 · wf-form4_168081442122928.xml · nonDerivative · entry 2 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,547 Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Alverson LukeSVP, GC & Secretary
|
Exercise / conversionCommon Stock | 4,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000019 · wf-form4_168081442122928.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
Exercise / conversionPerformance Rights · Derivative | 12,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000017 · wf-form4_168081439196812.xml · derivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,735 Underlying: Common Stock · 12,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 220 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 220 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 220 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 8,698 | $138.93 | $1,208,413.14 |
DisclosureSEC source: 0001624794-23-000017 · wf-form4_168081439196812.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,584 Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 22,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000017 · wf-form4_168081439196812.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Perry James EEVP, CFO
|
Exercise / conversionPerformance Rights · Derivative | 7,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000018 · wf-form4_168081440665019.xml · derivative · entry 3 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,598 Underlying: Common Stock · 7,279 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 116 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 116 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 116 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Perry James EEVP, CFO
|
Tax withholdingCommon Stock | 5,141 | $138.93 | $714,239.13 |
DisclosureSEC source: 0001624794-23-000018 · wf-form4_168081440665019.xml · nonDerivative · entry 2 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,065 Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Perry James EEVP, CFO
|
Exercise / conversionCommon Stock | 13,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000018 · wf-form4_168081440665019.xml · nonDerivative · entry 1 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Sullivan DonEVP, GM Contractor Solutions
|
Exercise / conversionPerformance Rights · Derivative | 3,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000016 · wf-form4_168081437307251.xml · derivative · entry 3 Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,398 Underlying: Common Stock · 3,945 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 76 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 76 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 76 dividend equivalent units, vested at 176.1% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Sullivan DonEVP, GM Contractor Solutions
|
Tax withholdingCommon Stock | 2,800 | $138.93 | $389,004.00 |
DisclosureSEC source: 0001624794-23-000016 · wf-form4_168081437307251.xml · nonDerivative · entry 2 Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,968 Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 20:53 UTC |
Sullivan DonEVP, GM Contractor Solutions
|
Exercise / conversionCommon Stock | 7,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000016 · wf-form4_168081437307251.xml · nonDerivative · entry 1 Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:09 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 72 | $133.69 | $9,625.68 |
DisclosureSEC source: 0001624794-23-000014 · wf-form4_167908377001719.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,176 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.42 to $134.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:09 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 209 | $132.47 | $27,686.23 |
DisclosureSEC source: 0001624794-23-000014 · wf-form4_167908377001719.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,248 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.26 to $133.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:09 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 340 | $131.60 | $44,744.00 |
DisclosureSEC source: 0001624794-23-000014 · wf-form4_167908377001719.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,457 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.25 to $132.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:09 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 379 | $130.75 | $49,554.25 |
DisclosureSEC source: 0001624794-23-000014 · wf-form4_167908377001719.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,797 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.14 to $131.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 21:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 7 | $143.11 | $1,001.77 |
DisclosureSEC source: 0001624794-23-000013 · wf-form4_167658357071355.xml · nonDerivative · entry 6 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,176 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 21:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 278 | $142.28 | $39,553.84 |
DisclosureSEC source: 0001624794-23-000013 · wf-form4_167658357071355.xml · nonDerivative · entry 5 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,183 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.86 to $142.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 21:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 456 | $141.17 | $64,373.52 |
DisclosureSEC source: 0001624794-23-000013 · wf-form4_167658357071355.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,461 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.81 to $141.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 21:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 100 | $140.36 | $14,036.00 |
DisclosureSEC source: 0001624794-23-000013 · wf-form4_167658357071355.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,917 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.81 to $140.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 21:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 93 | $139.31 | $12,955.83 |
DisclosureSEC source: 0001624794-23-000013 · wf-form4_167658357071355.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,017 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.78 to $139.77, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 21:39 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 66 | $138.42 | $9,135.72 |
DisclosureSEC source: 0001624794-23-000013 · wf-form4_167658357071355.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,110 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.78 to $138.77, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 06, 2023 Filed Feb 6, 2023 22:05 UTC |
Alverson LukeSVP, GC & Secretary
|
GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000011 · wf-form4_167572108926250.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,130 F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund. Read SEC document |
| February 06, 2023 Filed Feb 6, 2023 22:05 UTC |
Perry James EEVP, CFO
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-23-000012 · wf-form4_167572111245946.xml · nonDerivative · entry 1 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,183 F1 · kind: Represents bona fide charitable gifts made by the Reporting Person. Read SEC document |
| January 17, 2023 Filed Jan 17, 2023 23:29 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 113 | $124.98 | $14,122.74 |
DisclosureSEC source: 0001624794-23-000001 · wf-form4_167399818145907.xml · nonDerivative · entry 6 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,176 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.98 to $125.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 17, 2023 Filed Jan 17, 2023 23:29 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 249 | $125.67 | $31,291.83 |
DisclosureSEC source: 0001624794-23-000001 · wf-form4_167399818145907.xml · nonDerivative · entry 5 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,289 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.09 to $126.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 17, 2023 Filed Jan 17, 2023 23:29 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 272 | $126.86 | $34,505.92 |
DisclosureSEC source: 0001624794-23-000001 · wf-form4_167399818145907.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,538 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.22 to $127.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 17, 2023 Filed Jan 17, 2023 23:29 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 189 | $127.62 | $24,120.18 |
DisclosureSEC source: 0001624794-23-000001 · wf-form4_167399818145907.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,810 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.23 to $128.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 17, 2023 Filed Jan 17, 2023 23:29 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 57 | $129.15 | $7,361.55 |
DisclosureSEC source: 0001624794-23-000001 · wf-form4_167399818145907.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,999 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.48 to $129.48, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 17, 2023 Filed Jan 17, 2023 23:29 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 120 | $130.41 | $15,649.20 |
DisclosureSEC source: 0001624794-23-000001 · wf-form4_167399818145907.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,056 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.87 to $130.87, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 30, 2022 Filed Nov 30, 2022 21:21 UTC |
Alverson LukeSVP, GC & Secretary
|
GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-22-000106 · wf-form4_166984327117575.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,480 F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund. Read SEC document |
| November 18, 2022 Filed Nov 18, 2022 22:00 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,158 | $121.41 | $140,592.78 |
DisclosureSEC source: 0001624794-22-000105 · wf-form4_166880880503611.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,176 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.13 to $121.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 18, 2022 Filed Nov 18, 2022 22:00 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 727 | $120.65 | $87,712.55 |
DisclosureSEC source: 0001624794-22-000105 · wf-form4_166880880503611.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,334 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.11 to $121.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 22:00 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 115 | $120.00 | $13,800.00 |
DisclosureSEC source: 0001624794-22-000105 · wf-form4_166880880503611.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,061 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:04 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 549 | $122.27 | $67,126.23 |
DisclosureSEC source: 0001624794-22-000087 · wf-form4_166620985861879.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,176 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.02 to $122.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:04 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,451 | $121.30 | $176,006.30 |
DisclosureSEC source: 0001624794-22-000087 · wf-form4_166620985861879.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,725 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.01 to $121.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 11, 2022 Filed Oct 11, 2022 20:54 UTC |
Garde DanielleSVP, Chief People Officer
|
GrantCommon Stock | 1,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-22-000086 · wf-form4_166552167810878.xml · nonDerivative · entry 1 Garde Danielle · CIK 0001949798 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,636 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:07 UTC |
Alverson LukeSVP, GC & Secretary
|
Tax withholdingCommon Stock | 720 | $119.80 | $86,256.00 |
DisclosureSEC source: 0001624794-22-000081 · wf-form4_166491404112439.xml · nonDerivative · entry 2 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,880 Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:07 UTC |
Alverson LukeSVP, GC & Secretary
|
GrantCommon Stock | 1,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-22-000081 · wf-form4_166491404112439.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,600 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:07 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 4,373 | $119.80 | $523,885.40 |
DisclosureSEC source: 0001624794-22-000080 · wf-form4_166491401293363.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,176 Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:07 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
GrantCommon Stock | 8,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-22-000080 · wf-form4_166491401293363.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,549 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:08 UTC |
Perry James EEVP, CFO
|
Tax withholdingCommon Stock | 901 | $119.80 | $107,939.80 |
DisclosureSEC source: 0001624794-22-000082 · wf-form4_166491409060115.xml · nonDerivative · entry 2 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,183 Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:08 UTC |
Perry James EEVP, CFO
|
GrantCommon Stock | 3,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-22-000082 · wf-form4_166491409060115.xml · nonDerivative · entry 1 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,084 F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.